Study of Talabostat and Cisplatin in Advanced Melanoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the antitumor activity and safety of the combination
of talabostat and cisplatin in patients with metastatic melanoma.